APA (7th ed.) Citation

MR, S., FJ, M., AL, Z., MA, F., DL, H., DA, S., . . . JS, F. (2001). Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. New England Journal of Medicine, 345(13), 948.

Chicago Style (17th ed.) Citation

MR, Smith, McGovern FJ, Zietman AL, Fallon MA, Hayden DL, Schoenfeld DA, Kantoff PW, and Finkelstein JS. "Pamidronate to Prevent Bone Loss During Androgen-deprivation Therapy for Prostate Cancer." New England Journal of Medicine 345, no. 13 (2001): 948.

MLA (9th ed.) Citation

MR, Smith, et al. "Pamidronate to Prevent Bone Loss During Androgen-deprivation Therapy for Prostate Cancer." New England Journal of Medicine, vol. 345, no. 13, 2001, p. 948.